SCHEMBL23890397

SCHEMBL23890397

CC(F)n1ccc2cccc(C(N)=O)c21

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 11/20 0.39
KDM4E B2RXH2 1/20 0.38
ALDH1A1 P00352 1/20 0.38
GAA P10253 1/20 0.38
IRAK4 Q9NWZ3 2/20 0.37
PDPK1 O15530 1/20 0.37
HTR2A P28223 1/20 0.36
ADRA1D P25100 1/20 0.36
PARP2 Q9UGN5 3/20 0.36
PARP3 Q9Y6F1 3/20 0.36
PLK4 O00444 1/20 0.36
CHEK1 O14757 1/20 0.36
AURKA O14965 1/20 0.36
DAPK3 O43293 1/20 0.36
MAP4K4 O95819 1/20 0.36
CSF1R P07333 1/20 0.36
RET P07949 1/20 0.36
FGFR1 P11362 1/20 0.36
PDGFRA P16234 1/20 0.36
LTK P29376 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28193895 0.88 PARP1 (0.41) PARP1KDM4EALDH1A1GAAIRAK4
SCHEMBL29782510 0.76 CNR1 (0.43) PARP1KDM4EALDH1A1PDPK1HTR2A
SCHEMBL9275405 0.76 PARP1 (0.44) PARP1KDM4EALDH1A1GAAPDPK1
SCHEMBL30082247 0.76 PARP1 (0.44) PARP1KDM4EALDH1A1GAAPDPK1
SCHEMBL28165019 0.72 PARP1 (0.41) PARP1KDM4EALDH1A1GAAPDPK1
SCHEMBL19279316 0.71 BTK (0.41) PARP1ADRA1DPARP2PARP3PLK4
SCHEMBL18937450 0.67 LPAR5 (0.34) HTR2ADYRK1BKEAP1
SCHEMBL14917590 0.66 EZH2 (0.48) PARP1KDM4EALDH1A1GAAIRAK4
SCHEMBL28165043 0.66 PARP1 (0.48) PARP1KDM4EALDH1A1GAAIRAK4
SCHEMBL10203774 0.65 SLC6A2 (0.43) KDM4EALDH1A1GAAHTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3889134-A1 COMPOUND FOR INHIBITING PGE2/EP4 SIGNALING TRANSDUCTION INHIBITING, PREPARATION METHOD THEREFOR, AND MEDICAL USES THEREOF Keythera (Suzhou) Pharmaceuticals Co. Ltd. (CN) 2021-10-06 EP disclosed